Ultrafiltration
System
Wave Bioreactor
Magnetic Stirrer
System
Vial Filling Line
Isolator System
Overall Solution Provider
BFS System
PFS Inspection System
Secondary Packaging System
AI and big data have been identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes.
AGC Biologics announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, currently owned by Novartis Gene Therapies.
Servier, a global independent pharmaceutical Group, and PRISM BioLab, a Japan based biotechnology company with proprietary small molecule drug discovery platform, “PepMetics™Technology”, today announced...
Bristol Myers Squibb will pay $650 million U.S. dollars to Eisai including $200 million U.S. dollars as payment toward Eisai research and development expenses.